1978
DOI: 10.1016/s0022-3476(78)80905-6
|View full text |Cite
|
Sign up to set email alerts
|

Response to influenza virus vaccine in children receivingchemotherapy for malignancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
16
0

Year Published

1980
1980
2013
2013

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(17 citation statements)
references
References 4 publications
1
16
0
Order By: Relevance
“…16 The benefit of a seasonal influenza booster vaccine in patients with hematologic malignancies remains controversial despite a number of well-designed studies. 14,17,18 Even less is known about the safety, immunogenicity and optimal dosing regimen of 2009 H1N1 vaccine in this group of patients, although several investigators have reported efficacy of single dosing in healthy adults and children. [10][11][12][13] Our data demonstrate that vaccination against 2009 pandemic H1N1 is associated with an acceptable safety profile in patients with treated and untreated hematologic malignancies.…”
Section: Discussionmentioning
confidence: 99%
“…16 The benefit of a seasonal influenza booster vaccine in patients with hematologic malignancies remains controversial despite a number of well-designed studies. 14,17,18 Even less is known about the safety, immunogenicity and optimal dosing regimen of 2009 H1N1 vaccine in this group of patients, although several investigators have reported efficacy of single dosing in healthy adults and children. [10][11][12][13] Our data demonstrate that vaccination against 2009 pandemic H1N1 is associated with an acceptable safety profile in patients with treated and untreated hematologic malignancies.…”
Section: Discussionmentioning
confidence: 99%
“…82 Herpes zoster and herpes simplex usually follow a self-limited, localized course, similar to that in the child with out ALL.8' We discontinue all chemo therapy during herpes infections, until resolution has clearly begun.…”
Section: Infectionmentioning
confidence: 98%
“…The results are often conflicting, and depend on the type of vaccine and viral strains involved, but all of them confirm that influenza vaccination is safe in such children as no serious adverse events have been observed and the proportion of mild adverse events is no different from that in healthy subjects. [13][14][15][16][17][18][19][20][21][22][23][24][25] The data concerning the immunogenicity of influenza vaccines in children with cancer are are also contradictory, with some reports indicating a sufficient immune response and others not. However, it has been clearly shown that two vaccine doses lead to a better response than one, and that prior exposure to the circulating viral strain seems to increase the likelihood of response.…”
Section: Safety and Immunogenicity Of Influenza Vaccinationmentioning
confidence: 99%
“…However, it has been clearly shown that two vaccine doses lead to a better response than one, and that prior exposure to the circulating viral strain seems to increase the likelihood of response. [13][14][15][16][17][18][19] The most recent studies of currently available vaccines include two involving children with leukemia or solid tumors in the same study population. 20,21 Both found that influenza vaccination induces a better immune reaction in children who have completed …”
Section: Safety and Immunogenicity Of Influenza Vaccinationmentioning
confidence: 99%